odalasvir (ACH-3102) - Alexion Pharma, J&J
sovaprevir (ACH 1625) - Alexion Pharma
Achillion: Corporate Presentation (Achillion) - Feb 12, 2015 - "Highlights of Clinical Results"; "ACH-3102 + Sovaprevir Phase 2 Trial"; "Combination of ACH-3102+Sovaprevir results is very rapid reduction in viral clearance"; "All subjects achieve HCV RNA level <LOQ in less than two weeks: Shortest time to clear HCV RNA as compared to other regimens, Time to clear HCV RNA is important to shorten treatment duration" 
P2 data Hepatitis C Virus
http://www.achillion.com/resourcefiles/it_1423688558/ACHN_CorpOverview_10Feb2015.pdf
 
Feb 12, 2015
 
.
 
77e331fa-d4fb-4416-97e1-5c28ef065e35.jpg